Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123734182 | 12373418 | 2 | F | 20160804 | 20160516 | 20160810 | EXP | DE-JNJFOC-20160512708 | JANSSEN | 48.00 | YR | A | M | Y | 0.00000 | 20160810 | MD | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123734182 | 12373418 | 1 | SS | STELARA | USTEKINUMAB | 1 | Subcutaneous | N | 0 | 90 | MG | SOLUTION FOR INJECTION | /month | ||||||
| 123734182 | 12373418 | 2 | SS | STELARA | USTEKINUMAB | 1 | Subcutaneous | N | 0 | 90 | MG | SOLUTION FOR INJECTION | /month | ||||||
| 123734182 | 12373418 | 3 | PS | STELARA | USTEKINUMAB | 1 | Subcutaneous | N | 125261 | 90 | MG | SOLUTION FOR INJECTION | /month | ||||||
| 123734182 | 12373418 | 4 | SS | ATORVASTATIN | ATORVASTATIN | 1 | Unknown | U | 0 | UNSPECIFIED | |||||||||
| 123734182 | 12373418 | 5 | SS | SIMVASTATIN. | SIMVASTATIN | 1 | Unknown | U | 0 | UNSPECIFIED | |||||||||
| 123734182 | 12373418 | 6 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 123734182 | 12373418 | 7 | C | ACETYLSALICYLIC ACID | ASPIRIN | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 123734182 | 12373418 | 8 | C | VALSARTAN. | VALSARTAN | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 123734182 | 12373418 | 9 | C | ATOZET | ATORVASTATIN CALCIUMEZETIMIBE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 123734182 | 12373418 | 10 | C | PROCORALAN | IVABRADINE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 123734182 | 12373418 | 11 | C | TORASEMID | TORSEMIDE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 123734182 | 12373418 | 12 | C | ALLOPURINOL. | ALLOPURINOL | 1 | Unknown | 0 | UNSPECIFIED |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123734182 | 12373418 | 1 | Psoriasis |
| 123734182 | 12373418 | 2 | Psoriatic arthropathy |
| 123734182 | 12373418 | 3 | Psoriasis |
| 123734182 | 12373418 | 4 | Product used for unknown indication |
| 123734182 | 12373418 | 5 | Product used for unknown indication |
| 123734182 | 12373418 | 6 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123734182 | 12373418 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123734182 | 12373418 | Blood creatine phosphokinase increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123734182 | 12373418 | 1 | 201202 | 0 | ||
| 123734182 | 12373418 | 2 | 201202 | 0 | ||
| 123734182 | 12373418 | 3 | 201202 | 0 | ||
| 123734182 | 12373418 | 4 | 2013 | 2015 | 0 | |
| 123734182 | 12373418 | 9 | 201506 | 0 |